This federal contract award is for the Arthrex ACP Double Syringe System, awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The fixed-price delivery order, valued at $1,650.00, has an ultimate completion date of November 8, 2024. Arthrex, a for-profit Subchapter S Corporation, has a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, valued at $471,048,172.66 and running from June 11, 2024, to September 1, 2029. This IDC allows VA medical centers nationwide to acquire Arthrex's innovative orthopedic technologies through task orders. The contract award does not have a set-aside designation, indicating Arthrex's competitive position in the open federal market.
Generated 2/4/25, 10:25 AM